Charles Schwab’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.82M Buy
935,352
+38,116
+4% +$224K ﹤0.01% 2404
2026
Q1
$3.97M Buy
897,236
+11,497
+1% +$68K ﹤0.01% 2494
2025
Q4
$4.74M Buy
885,739
+223,778
+34% +$1.78M ﹤0.01% 2478
2025
Q3
$6.37M Buy
661,961
+487,033
+278% +$4.49M ﹤0.01% 2322
2025
Q2
$1.29M Buy
174,928
+9,564
+6% +$64.1K ﹤0.01% 2821
2025
Q1
$776K Buy
165,364
+7,138
+5% +$35.6K ﹤0.01% 2932
2024
Q4
$717K Buy
158,226
+37,948
+32% +$202K ﹤0.01% 3029
2024
Q3
$334K Buy
120,278
+17,159
+17% +$45.6K ﹤0.01% 3265
2024
Q2
$316K Buy
+103,119
New +$398K ﹤0.01% 3357

Other funds holding ASPI

Charles Schwab's ASPI Position: Q2 2026 in Review

Charles Schwab increased its ASP Isotopes (ASPI) stake by 4.2% in Q2 2026, buying an estimated $224K and bringing the position to 935,352 shares worth $5.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2404.

Charles Schwab first reported a position in ASPI in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.37M in Q3 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.

  • Charles Schwab held 935,352 shares of ASP Isotopes worth $5.82M as of Q2 2026.
  • Charles Schwab bought 38,116 ASP Isotopes shares in Q2 2026, an estimated $224K.
  • ASP Isotopes made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2404 holding.
  • Charles Schwab first reported a position in ASP Isotopes in Q2 2024 and has held it in 9 quarters since.
  • Charles Schwab's ASP Isotopes position peaked at $6.37M in Q3 2025.
  • 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.